Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis

OBJECTIVES: Opioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as efficacy and safety of naloxegol, in patients with cancer with OIC. METHODS: An observational study was made of a cohort of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Cobo Dols, Manuel, Beato Zambrano, Carmen, Cabezón Gutiérrez, Luis, Chicas Sett, Rodolfo, Blancas López-Barajas, María Isabel, García Navalón, Francisco, Fírvida Pérez, José Luis, Serrano Bermúdez, Gala, Togores Torres, Pilar, Delgado Mingorance, Ignacio, Giraldo Marín, Alexandra, Librán Oriol, Anna, Paredes Lario, Alfredo, Sánchez Mauriño, Pedro, Higuera Gómez, Oliver, Moreno Muñoz, Diana, Jiménez López, Antonio Javier, Huerta González, Ibone, Sanz Yagüe, Almudena, Soler López, Begoña
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907572/
https://www.ncbi.nlm.nih.gov/pubmed/32376758
http://dx.doi.org/10.1136/bmjspcare-2020-002249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907572/
https://www.ncbi.nlm.nih.gov/pubmed/32376758
http://dx.doi.org/10.1136/bmjspcare-2020-002249

Ejemplares similares